RxDoctor Payments Data

Bridgette Cooke, PA

Physician Assistant · Statesville, NCNPI 1023504735

Payments from drug & device makers

$9,987in general payments, 2019–2025

Across 581 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • UCB, Inc.$644
  • Bristol Myers Squibb$482
  • Impel Pharmaceuticals Inc.$317
  • Sunovion Pharmaceuticals Inc.$317
  • plus $6K from 54 others

What the payments were for

  • Speaking & faculty fees$350%
  • Food & beverage$9,59796%
  • Education$3564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie102$1,465
Teva Pharmaceuticals USA, Inc.74$1,153
UCB, Inc.36$644
Bristol Myers Squibb25$482
Impel Pharmaceuticals Inc.29$317
Sunovion Pharmaceuticals Inc.19$317
Amgen25$315
Novartis22$302
Neurocrine Biosciences, Inc.14$292
Biogen16$285
Acadia Pharmaceuticals Inc11$279
Jazz Pharmaceuticals Inc.13$273
SK Life Science, Inc.13$253
TG Therapeutics, Inc.5$225
Pfizer17$221
Biohaven Pharmaceuticals, Inc.11$221
EMD Serono, Inc.5$219
Lilly USA, LLC11$203
Neurelis, Inc.8$162
Lundbeck LLC7$146
Argenx US, Inc.5$133
Merz Pharmaceuticals, LLC6$133
Acorda Therapeutics, Inc7$125
Averitas Pharma Inc.6$119
Impel Pharmaceuticals LLC6$113
Greenwich Biosciences, Inc.5$110
Eisai Inc.7$107
MDD US Operations, LLC5$103
Takeda Pharmaceuticals U.S.A., Inc.5$102
Avadel CNS Pharmaceuticals, LLC4$84
Almatica Pharma LLC4$80
GRT US Holding, Inc.5$62
Upsher-smith Laboratories LLC4$62
Amneal Pharmaceuticals LLC4$62
Sanofi3$60
Genentech USA, Inc.3$59
AstraZeneca(2 entities)3$56
GE HealthCare3$54
Avion Pharmaceuticals3$49
Kyowa Kirin, Inc.2$47
Johnson & Johnson3$45
Livanova USA, Inc.2$39
Sumitomo Pharma America, Inc.3$36
Avanir Pharmaceuticals, Inc.2$36
Biohaven Pharmaceutical Holding Company Ltd.2$33
Medtronic1$31
Aucta Pharmaceuticals, Inc.2$28
Axsome Therapeutics, Inc.1$27
Noctrix Health, Inc.1$25
Banner Life Sciences, LLC1$25
Tersera Therapeutics LLC1$21
CSL Behring1$20
Tanabe Pharma America, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
Collegium Pharmaceutical, Inc.1$18
Idorsia Pharmaceuticals US Inc1$18
Azurity Pharmaceuticals, Inc.1$15
Scilex Pharmaceuticals Inc.1$15
Inspire Medical Systems, Inc.1$15
Mallinckrodt Hospital Products Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,987 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$567,792
Medicare patients
185
Services billed
27,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate87$116,357
BriviactBrivaracetam59$101,403
UbrelvyUbrogepant51$71,165
QuliptaAtogepant49$67,759
NuplazidPimavanserin Tartrate13$63,636
Emgality PenGalcanezumab-Gnlm79$62,085
Ajovy AutoinjectorFremanezumab-Vfrm25$19,560
LamictalLamotrigine17$17,245
TrintellixVortioxetine Hydrobromide26$16,164
Aimovig AutoinjectorErenumab-Aooe13$13,617
ZavzpretZavegepant Hcl11$12,715
NamzaricMemantine Hcl/Donepezil Hcl16$12,298
NayzilamMidazolam17$11,099
Dalfampridine ErDalfampridine19$7,350
Memantine Hcl109$5,128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta, Namzaric$1,465$151,222116 claims
PfizerNurtec Odt, Zavzpret$221$129,07198 claims
UCB, Inc.Briviact, Nayzilam$644$112,50276 claims
Acadia Pharmaceuticals IncNuplazid$279$63,63613 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$102$16,16426 claims
Upsher-smith Laboratories LLCTopiramate$62$946108 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Statesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →